Mayne Pharma Group Limited (MYX.AX) has a MoatMap StockRank of 19/100 based on Quality (38/100), Value (48/100), and Momentum (23/100) factor scores. The current signal is STRONG SELL. Mayne Pharma Group Limited, an Australian healthcare company, does not have a clear, direct, and unpriced macro tailwind from the identified themes. Small-cap healthcare companies, especially pharma, often carry significant R&D and regulatory risks, making it difficult to qualify them as quality compounders with durable moats and predictable high ROIC.